Role of serum HBV RNA and hepatitis B surface antigen levels in identifying Asian patients with chronic hepatitis B suitable for entecavir cessation
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of serum HBV RNA and hepatitis B surface antigen levels in identifying Asian patients with chronic hepatitis B suitable for entecavir cessation
Authors
Keywords
-
Journal
GUT
Volume -, Issue -, Pages gutjnl-2020-321116
Publisher
BMJ
Online
2020-08-06
DOI
10.1136/gutjnl-2020-321116
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Serum alanine aminotransferase flares in chronic hepatitis B infection: the good and the bad
- (2020) Marc G Ghany et al. Lancet Gastroenterology & Hepatology
- New Biomarkers of Chronic Hepatitis B
- (2019) Lung-Yi Mak et al. Gut and Liver
- Association Between Negative Results From Tests for HBV DNA and RNA and Durability of Response After Discontinuation of Nucles(t)ide Analogue Therapy
- (2019) Rong Fan et al. Clinical Gastroenterology and Hepatology
- Limited sustained response after stopping nucleos(t)ide analogues in patients with chronic hepatitis B: results from a randomised controlled trial (Toronto STOP study)
- (2019) Kin Seng Liem et al. GUT
- Pre‐genomic HBV RNA and HBcrAg predict outcomes in HBeAg negative chronic hepatitis B patients suppressed on nucleos(t)ide analogue therapy
- (2019) Ivana Carey et al. HEPATOLOGY
- Safety, pharmacokinetics, and antiviral effects of ABI-H0731, a hepatitis B virus core inhibitor: a randomised, placebo-controlled phase 1 trial
- (2019) Man-Fung Yuen et al. Lancet Gastroenterology & Hepatology
- Incidence and predictors of hepatitis B surface antigen seroclearance after cessation of nucleos(t)ide analogue therapy in hepatitis B e antigen-negative chronic hepatitis B
- (2018) Wen-Juei Jeng et al. HEPATOLOGY
- Relationship between serum HBV-RNA levels and intrahepatic viral as well as histologic activity markers in entecavir-treated patients
- (2018) Jing Wang et al. JOURNAL OF HEPATOLOGY
- The Role of Hepatitis B Surface Antigen in Nucleos(t)ide Analogues Cessation among Asian Chronic Hepatitis B Patients: A Systematic Review
- (2018) Jiaye Liu et al. HEPATOLOGY
- American Gastroenterological Association Institute Guideline on the Role of Elastography in the Evaluation of Liver Fibrosis
- (2017) Joseph K. Lim et al. GASTROENTEROLOGY
- Serum HBV pgRNA as a clinical marker for cccDNA activity
- (2017) Katja Giersch et al. JOURNAL OF HEPATOLOGY
- EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
- (2017) Pietro Lampertico et al. JOURNAL OF HEPATOLOGY
- Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients – FINITE study
- (2017) Thomas Berg et al. JOURNAL OF HEPATOLOGY
- Effects of nucleoside analogue prescription for hepatitis B on the incidence of liver cancer in Hong Kong: a territory-wide ecological study
- (2016) W.-K. Seto et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Assessing the Durability of Entecavir-Treated Hepatitis B Using Quantitative HBsAg
- (2016) Chia-Chi Wang et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Clinical Relapse After Cessation of Tenofovir Therapy in Hepatitis B e Antigen–Negative Patients
- (2016) Wen-Juei Jeng et al. Clinical Gastroenterology and Hepatology
- Intrahepatic hepatitis B virus replication and liver histology in subjects with occult hepatitis B infection
- (2016) D.K.-H. Wong et al. CLINICAL MICROBIOLOGY AND INFECTION
- Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update
- (2015) S. K. Sarin et al. Hepatology International
- Hepatitis B surface antigen seroclearance during nucleoside analogue therapy: surface antigen kinetics, outcomes, and durability
- (2015) Wai-Kay Seto et al. JOURNAL OF GASTROENTEROLOGY
- Longitudinal profiles of highly sensitive hepatitis B surface antigen levels: re-evaluation of HBsAg seroclearance
- (2015) Wai-Kay Seto et al. LIVER INTERNATIONAL
- Treatment cessation of entecavir in Asian patients with hepatitis B e antigen negative chronic hepatitis B: a multicentre prospective study
- (2014) Wai-Kay Seto et al. GUT
- HBsAg seroclearance after nucleoside analogue therapy in patients with chronic hepatitis B: clinical outcomes and durability
- (2013) Gi-Ae Kim et al. GUT
- A large case-control study on the predictability of hepatitis B surface antigen levels three years before hepatitis B surface antigen seroclearance
- (2012) Wai-Kay Seto et al. HEPATOLOGY
- Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
- (2012) Patrick Marcellin et al. LANCET
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now